Literature DB >> 1339461

Identification of sequence types among the M-nontypeable group A streptococci.

W A Relf1, D R Martin, K S Sriprakash.   

Abstract

Streptococcal diseases, namely, acute glomerulonephritis and acute rheumatic fever, are common features in the aboriginal population of the Northern Territory of Australia. We examined the group A streptococcal M types identified during various surveys conducted since 1987. Streptococci were predominantly isolated from skin infections. A high proportion of the isolates could not be serotyped by conventional means and were designated M nontypeable (MNT). M-specific DNA sequences from the MNT isolates were examined, and sequence types were proposed for the classification of MNTs. This allowed a more precise estimate of the M types present in a population study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339461      PMCID: PMC270620          DOI: 10.1128/jcm.30.12.3190-3194.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Acute rheumatic fever and rheumatic heart disease in a rural central Australian aboriginal community.

Authors:  R E Brennan; M S Patel
Journal:  Med J Aust       Date:  1990-09-17       Impact factor: 7.738

2.  Opacity factor from group A streptococci is an apoproteinase.

Authors:  G A Saravani; D R Martin
Journal:  FEMS Microbiol Lett       Date:  1990-03-01       Impact factor: 2.742

3.  Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49.

Authors:  E J Haanes; P P Cleary
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

4.  Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.

Authors:  E H Beachey; J M Seyer
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

5.  Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences.

Authors:  J C Robbins; J G Spanier; S J Jones; W J Simpson; P P Cleary
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

6.  Streptococcal infection and renal disease markers in Australian aboriginal children.

Authors:  P G Van Buynder; J A Gaggin; D Martin; D Pugsley; J D Mathews
Journal:  Med J Aust       Date:  1992-04-20       Impact factor: 7.738

7.  Fc-receptor and M-protein genes of group A streptococci are products of gene duplication.

Authors:  D G Heath; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci.

Authors:  A Podbielski; B Melzer; R Lütticken
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

9.  Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes.

Authors:  E Frithz; L O Hedén; G Lindahl
Journal:  Mol Microbiol       Date:  1989-08       Impact factor: 3.501

10.  Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.

Authors:  E H Beachey; J M Seyer; J B Dale
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  15 in total

1.  Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Authors:  E R Brandt; T Teh; W A Relf; R I Hobb; M F Good
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Group A streptococcal Vir types are M-protein gene (emm) sequence type specific.

Authors:  D L Gardiner; A M Goodfellow; D R Martin; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995.

Authors:  B Beall; R Facklam; T Hoenes; B Schwartz
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

4.  Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.

Authors:  S Kawabata; E Kunitomo; Y Terao; I Nakagawa; K Kikuchi; K Totsuka ; S Hamada
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Identification of M types of group A streptococci.

Authors:  A Kaufhold; A Podbielski; P Kriz-Kuzemenska
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

6.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

7.  Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein.

Authors:  L M Mejia; K E Stockbauer; X Pan; A Cravioto; J M Musser
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

8.  Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection.

Authors:  Fiona C McKay; Jason D McArthur; Martina L Sanderson-Smith; Sandra Gardam; Bart J Currie; Kadaba S Sriprakash; Peter K Fagan; Rebecca J Towers; Michael R Batzloff; Gursharan S Chhatwal; Marie Ranson; Mark J Walker
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Protective immunity to the group A Streptococcus may be only strain specific.

Authors:  S A de Malmanche; D R Martin
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

10.  Multiple strains of Streptococcus pyogenes in skin sores of aboriginal Australians.

Authors:  J Carapetis; D Gardiner; B Currie; J D Mathews
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.